NewsRARE Journal: MCDA methodology, an alternative model for the evaluation of new orphan drugs

//NewsRARE Journal: MCDA methodology, an alternative model for the evaluation of new orphan drugs

NewsRARE Journal: MCDA methodology, an alternative model for the evaluation of new orphan drugs

Now available the 5th new edition of NewsRARE Journal, including an editorial from Dr. Badia, OmakaseConsulting CEO, and an interview with Dr. Jose Luis Poveda, Head of the Pharmacy Service of the University and Polytechnic Hospital of La Fe in Valencia

Download the editorial and interview here: newsRARE n5

2020-09-08T15:24:21+00:00February 28th, 2020|News & Events|

Leave A Comment

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies